[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU2003243058A8 - Methods for using the cd163 pathway for modulating an immune response - Google Patents

Methods for using the cd163 pathway for modulating an immune response

Info

Publication number
AU2003243058A8
AU2003243058A8 AU2003243058A AU2003243058A AU2003243058A8 AU 2003243058 A8 AU2003243058 A8 AU 2003243058A8 AU 2003243058 A AU2003243058 A AU 2003243058A AU 2003243058 A AU2003243058 A AU 2003243058A AU 2003243058 A8 AU2003243058 A8 AU 2003243058A8
Authority
AU
Australia
Prior art keywords
pathway
modulating
methods
immune response
immune
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003243058A
Other versions
AU2003243058A1 (en
Inventor
Ruprecht Jules Joost V Neerven
Louis Boon
Petrus Johannes Simons
David Speijer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIOCEROS BV
Macrozyme BV
Original Assignee
BIOCEROS BV
Macrozyme BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP02077071A external-priority patent/EP1367393A1/en
Application filed by BIOCEROS BV, Macrozyme BV filed Critical BIOCEROS BV
Publication of AU2003243058A1 publication Critical patent/AU2003243058A1/en
Publication of AU2003243058A8 publication Critical patent/AU2003243058A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596Molecules with a "CD"-designation not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/70Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/70Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/30Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70596Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003243058A 2002-05-27 2003-05-27 Methods for using the cd163 pathway for modulating an immune response Abandoned AU2003243058A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US38368902P 2002-05-27 2002-05-27
EP02077071A EP1367393A1 (en) 2002-05-27 2002-05-27 Methods for using the CD 163 pathway for modulating an immune response
US60/383,689 2002-05-27
EP02077071.5 2002-05-27
PCT/NL2003/000395 WO2003100419A1 (en) 2002-05-27 2003-05-27 Methods for using the cd163 pathway for modulating an immune response

Publications (2)

Publication Number Publication Date
AU2003243058A1 AU2003243058A1 (en) 2003-12-12
AU2003243058A8 true AU2003243058A8 (en) 2003-12-12

Family

ID=29585706

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003243058A Abandoned AU2003243058A1 (en) 2002-05-27 2003-05-27 Methods for using the cd163 pathway for modulating an immune response

Country Status (2)

Country Link
AU (1) AU2003243058A1 (en)
WO (1) WO2003100419A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10303974A1 (en) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid β (1-42) oligomers, process for their preparation and their use
EP1660133B1 (en) * 2003-05-15 2018-04-18 Therapure Biopharma Inc. Targeted delivery of anti-viral compounds through hemoglobin bioconjugation
JP5273642B2 (en) * 2004-04-23 2013-08-28 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー Cellular tolerance factor to virus and use of the factor
KR101667623B1 (en) 2005-11-30 2016-10-19 애브비 인코포레이티드 Monoclonal antibodies against amyloid beta protein and uses thereof
ES2527661T3 (en) 2005-11-30 2015-01-28 Abbvie Inc. Scanning method, process for purifying non-spreadable Abeta oligomers, selective antibodies against said spreadable Abeta oligomers and a process for making said antibodies
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
EP2124952A2 (en) 2007-02-27 2009-12-02 Abbott GmbH & Co. KG Method for the treatment of amyloidoses
GB0917054D0 (en) * 2009-09-29 2009-11-11 Cytoguide As Agents, uses and methods
GB0917044D0 (en) * 2009-09-29 2009-11-18 Cytoguide As Agents, uses and methods
CN102933601B (en) 2010-04-15 2016-06-08 Abbvie公司 Amyloid beta binding proteins
CN103298833B (en) 2010-08-14 2015-12-16 Abbvie公司 Amyloid beta associated proteins
US11986536B2 (en) 2019-03-23 2024-05-21 Ablevia Biotech Gmbh Compound for the sequestration of undesirable antibodies in a patient
US11634501B2 (en) * 2019-07-19 2023-04-25 Oncoresponse, Inc. Immunomodulatory antibodies and methods of use thereof
AU2020344554A1 (en) * 2019-09-09 2022-03-31 The Children's Hospital Of Philadelphia Compositions and methods for treatment of disorders associated with CLEC16A dysfunction or loss
WO2022063879A1 (en) * 2020-09-23 2022-03-31 Ablevia Biotech Gmbh Compound for the sequestration of undesirable antibodies in a patient

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002210383A1 (en) * 2000-10-16 2002-04-29 Proteopharma Aps The function of a haptoglobin-haemoglobin receptor and the uses thereof

Also Published As

Publication number Publication date
AU2003243058A1 (en) 2003-12-12
WO2003100419A1 (en) 2003-12-04

Similar Documents

Publication Publication Date Title
GB2384570B (en) Modulators
ZA200409641B (en) Novel substituted indoles.
EP1494693A4 (en) Cripto-specific antibodies
EP1465179A4 (en) Disc apparatus
EP1535749A4 (en) Bookmaking apparatus
AU2003243058A8 (en) Methods for using the cd163 pathway for modulating an immune response
EP1587483A4 (en) Methods for modulating an inflammatory response
GB2422544B (en) Immune modulator
GB0220809D0 (en) Immune modulator
GB0208928D0 (en) Methods
AU2003282335A1 (en) Firearm simulation device
GB0220045D0 (en) Methods
GB0221711D0 (en) Methods
GB0226878D0 (en) Antibodies
AU2003264722A8 (en) Methods
AU155673S (en) Wheel for an outdoor cooking device
GB0222276D0 (en) Methods
GB0225663D0 (en) Methods and means for modulating the immune response
GB0200526D0 (en) Methods
GB0213580D0 (en) Methods
GB0213579D0 (en) Methods
GB2388238B (en) An interactive system
GB0217243D0 (en) Fab-u-met holdback
GB0220808D0 (en) Immune modulator
ZA200209082B (en) Barbeque apparatus.

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
TH Corrigenda

Free format text: IN VOL 18, NO 5, PAGE(S) 1100 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME BIOCEROS B.V. I.O., APPLICATION NO. 2003243058, UNDER INID (71) CORRECT THE NAME TO READ BIOCEROS B.V.; MACROZYME B.V.